One of these studies demonstrated a 1.7-fold higher recovery of toxic metabolites in those with Gilbert’s syndrome compared to controls [33], although a larger study only found a higher rate of recovery of toxic metabolites in those patients stratified by having the lowest UGT activity [28]. This evidence concerns the gene SLC35A2 and Gilbert syndrome.